Is your air clean? Find out with Amazon's smart air quality monitor for 36% off for Prime Day
Amazon Prime Day is almost here, and it is the perfect time to save big on some of Amazon's most trusted smart home devices. If you've ever wondered about the quality of the air you're breathing, or have specific concerns about pollutants in your home, now's your chance to take control.
The Prime Day sale runs from Tuesday, July 8 through Friday, July 11, but the Amazon Smart Air Quality Monitor is already available for 36% off for Prime members. This compact yet powerful device helps you stay informed about what's in the air around you by tracking key air quality indicators, including:
Limited Prime deal: 36% off the Amazon Smart Air Quality Monitor
An air purifier is one of the best ways to cleanse the air in your home of harmful air pollutants, including smoke and dust. But, if you have concerns about the air quality in your home, you can up the ante by investing in a smart home device such as the Amazon Smart Air Quality Monitor to keep track of levels.
The Amazon Smart Air Quality Monitor features a color-coded LED light that gives you a quick visual of your air quality score. For even more convenience, you can connect it to your Alexa-enabled devices to get hands-free updates and insights.
But it doesn't stop there—this monitor can also trigger Alexa Routines. That means your air purifier, dehumidifier or fan can automatically turn on when air quality dips, so you don't have to lift a finger to improve your environment.
While the device works independently via the Alexa app and its built-in LED, it's most powerful when paired with an Alexa device. Just note that it doesn't include a microphone, speaker or audible alarm—so for full functionality, an Alexa companion is recommended.
Save 36% at Amazon
More: This genius solar-powered fan hat is on sale for Prime Day
Amazon Prime Day will take place from Tuesday, July 8 through Friday, July 11. The savings will officially begin at 12:00am PT/3am ET on July 8.
Yes, in order to access the best Prime Day deals, you'll want to sign up for an Amazon Prime membership. New members can try one week of Amazon Prime benefits for just $1.99 right now.
Amazon Prime for Young Adults is back! Do you qualify for the discount? Find out here
USA TODAY Shopping will be covering all the savings throughout Prime Day 2025, so be sure to sign up for text alerts, subscribe for our newsletter and follow us on Instagram to stay updated!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
35 minutes ago
- Miami Herald
UnitedHealth's campaign to quiet critics
Mary Strause, a filmmaker in Wisconsin, logged on to Amazon's video-streaming service in late May so she could share a link to her latest project, a docuseries that harshly criticized the U.S. health care industry. She was surprised to see that her video had vanished. Strause had no way of knowing it, but the video had been taken down after a law firm working for UnitedHealth Group, one of the country's largest health care companies, sent a letter warning Amazon and another streaming service, Vimeo, that the video was defamatory. It was the latest salvo in an aggressive and wide-ranging campaign to quiet critics. In recent months, UnitedHealth has targeted traditional journalists and news outlets, a prominent investor, a Texas doctor and activists like Strause and her father, who complained about a UnitedHealth subsidiary. In legal letters and court filings, UnitedHealth has invoked last year's killing of Brian Thompson, the CEO of the company's health insurance division, to argue that intense criticism of the company risks inciting further violence. The tactics have had an impact. Amazon and Vimeo both removed Strause's film. The Guardian postponed publishing an investigation of the company after UnitedHealth sued over a previous article it said was defamatory. UnitedHealth joins a growing group of companies and wealthy individuals, including President Donald Trump, who are using legal threats and lawsuits to deter or penalize criticism. Over the years, there have been scattered examples of embattled companies -- such as Purdue Pharma, the maker of the highly addictive painkiller OxyContin -- deploying legal offensives against a broad spectrum of journalists and critics, said Lee Levine, a retired First Amendment lawyer who has defended news outlets, including The New York Times. 'Some version of this has been going on for a long, long time,' Levine said. But, he added, 'the incidence of it has increased.' For UnitedHealth, the stakes are high. In recent years, the company has been the subject of extensive investigative reporting into its billing practices and denials of patient care, among other things. It faces a variety of federal criminal and civil investigations, including into potential Medicare fraud and antitrust violations, The Wall Street Journal has reported. 'Negative publicity may adversely affect our stock price, damage our reputation and expose us to unexpected or unwarranted regulatory scrutiny,' UnitedHealth noted in its most recent annual report. The company's shares have declined 40% over the past year. Eric Hausman, a spokesperson for UnitedHealth, defended the company's efforts. 'The truth matters, and there's a big difference between 'criticism' and irresponsibly omitting facts and context,' he said in a statement. 'When others get it wrong, we have an obligation to our customers, employees and other stakeholders to correct the record, including by making our case in court when necessary.' Even before Thompson was fatally shot in December on his way into a Manhattan hotel, the company had been seeking to tamp down negative publicity. In March 2024, The Examiner News in Mount Kisco, New York, published its latest investigation of a UnitedHealth division, Optum Medical Care, that operated in the area. A source had provided Adam Stone, the newspaper's publisher, with a recording of Optum employees, and Stone said he inadvertently posted the whole file, rather than a snippet, with his article. Within hours, he had corrected the mistake -- but not before Optum had noticed. About a week later, Stone received a letter from the executive who ran Optum in New York and New Jersey, saying he had potentially committed a crime by airing audio that included private information about patients. The executive demanded that Stone destroy the audio and said the company might seek a court injunction barring him from continuing to publish it. Stone replied that he would not destroy the audio. An Optum lawyer then wrote a letter reiterating the demand. Stone again refused. It was the last he heard from the company. 'The aim was to use scare tactics to intimidate,' Stone said. UnitedHealth's efforts intensified after Thompson's killing. In early January, Dr. Elisabeth Potter, a plastic surgeon in Austin, Texas, posted a self-made video on TikTok and Instagram that described how she had interrupted breast-reconstruction surgery to respond to a phone call from UnitedHealth about whether the insurer would cover a patient's stay at a hospital. The call had come to the operating room's phone line, leading her to believe it was urgent. 'Insurance is out of control,' Potter said in the video. 'I have no other words.' The short video was viewed millions of times and attracted hundreds of thousands of 'likes' on social media. About a week later, Potter received a six-page letter from the law firm Clare Locke, which UnitedHealth had retained as 'defamation counsel.' The letter claimed that she had distorted the circumstances of the phone call and that her video was libelous. It noted that some commenters were responding to her posts by celebrating Thompson's killing. The letter demanded that she retract her video and apologize. A lawyer for Potter sent a letter to Clare Locke defending the accuracy of the video. The law firm did not respond, Potter said. One of the many people who shared Potter's video was billionaire investor Bill Ackman, who has nearly 2 million followers on the social platform X and regularly wades into controversies. In a post accompanying the video, he suggested that investors should bet against UnitedHealth's stock and that the Securities and Exchange Commission should investigate the company. The post brought even more attention to Potter's video. Ackman soon heard from Clare Locke. He already knew the firm. He and his wife, Neri Oxman, had hired Clare Locke to threaten Business Insider after it reported in 2024 that she had plagiarized parts of her doctoral dissertation. (They did not end up suing.) Now, though, the roles were reversed. One of the firm's co-founders called an aide to Ackman and told him that the video included falsehoods. And UnitedHealth contacted the SEC to complain that Ackman was trying to drive down the company's stock price. Ackman deleted the post. But after he spoke with Potter and looked at notes and call logs provided by her lawyer, he changed course. 'I believe that Dr. Potter told the truth,' he wrote on X in February. He accused UnitedHealth of 'brazen attempts to silence UNH's critics.' Clare Locke never followed up with him. Still, Potter's conflict with the company was not over, she said. She had recently opened her own surgery center and had hired a consultant to help persuade UnitedHealth and other insurers to classify it as an in-network provider. Winning that designation was essential to Potter's business plan. Then Potter's video went viral, and UnitedHealth stopped responding to inquiries from her representative, she said. Potter perceived it as retaliation. Although she said she was still in talks with other major insurers, UnitedHealth is the country's largest. She said she worried that her surgery center might have to close. At the time that she posted the video, Potter hadn't anticipated UnitedHealth's reaction. 'I guess I was naive,' she said. Hausman, the UnitedHealth spokesperson, said the insurer had decided not to designate Potter's center as in-network before she posted her video. In May, The Guardian published an investigation that said UnitedHealth had sought to save money by discouraging nursing homes from sending sick residents to the hospital. The article -- which was based on lawsuits, internal company documents, patient records and interviews -- noted that UnitedHealth disputed its findings. Last month, UnitedHealth sued The Guardian for defamation. The lawsuit accused the news organization of deliberately publishing false accusations and 'brazenly trying to capitalize on the tragic and shocking assassination' of Thompson. The Guardian said it stood by its reporting and was preparing to defend itself against the lawsuit. The timing of the lawsuit was notable. It was filed the day before The Guardian was scheduled to publish a second investigation into UnitedHealth, according to people familiar with the plans. The news organization had informed UnitedHealth about the article's timing. After the lawsuit was filed, editors at The Guardian decided to postpone publication of the second piece, the people said. It hasn't yet run. It was around this time that Strause, the filmmaker from Wisconsin, logged on to Amazon's video-streaming service to get a link to share with a friend. Strause and her father, Dan Strause, who had helped run a small chain of pharmacies in Wisconsin, had hoped that the docuseries, called 'Modern Medical Mafia,' would reveal the inner workings of drug industry middlemen known as pharmacy benefit managers, or PBMs. One of the largest PBMs, Optum Rx, is a UnitedHealth subsidiary. The show's central premise was that PBMs operated like an organized-crime ring, using their dominant market positions to push prescription prices ever higher. The first episode included interviews with two members of Congress and several prominent critics of PBMs and featured computer-generated animations of shadow-cloaked businesspeople and gangsters. A trailer for the series went online late last year, and UnitedHealth learned that it was going to be available on platforms including Amazon Prime Video. In January, Clare Locke flagged UnitedHealth's concerns in a letter to Amazon's outside counsel. The episode nonetheless became available on Prime Video in late March. On May 21, Clare Locke wrote again to Amazon's lawyers. The 16-page letter claimed that the docuseries 'spreads a vociferous and false screed in a thinly-veiled call to violence for anyone who is dissatisfied with the American health care system. Recent history and Brian Thompson's murder demonstrates the devastating and irreversible consequences of ginning up such hatred with false claims designed to inspire violence.' The letter said the video violated Amazon's terms of service and should be removed, in part because it 'doxxed our clients' physical address' by showing a street sign for Optum Way in Minnesota. Within days, the video -- which had no more than a few hundred views -- had been removed from Prime Video. Strause contacted Filmhub, the company that had helped place the documentary on the platform, to ask why. 'Channels occasionally decline and remove titles that they say are not aligned with their ever-changing content policies,' Filmhub responded, noting that Amazon's decision was not subject to appeal. (An Amazon spokesperson, Katie Barker, said in a statement that Filmhub decided to have 'Modern Medical Mafia' removed after Amazon flagged its 'low video quality.' Filmhub executives did not respond to requests for comment.) In early June, Strause received an email from Vimeo, where 'Modern Medical Mafia' had also been available for streaming. 'This content was removed due to a complaint Vimeo received concerning defamation,' the email said. 'Vimeo is not able to evaluate the truth or falsity of such a claim, and it asks that you resolve the dispute directly with the complainants, Optum Rx and UnitedHealth Group.' To Strause, UnitedHealth's determination to get her video taken down showed that she and her father were exposing the truth. 'They're intimidated by what we're saying,' she said. The video remains available on YouTube, which said it had not received a request to remove it, and Strause said she planned to upload the rest of the series to that platform later this year. This article originally appeared in The New York Times. Copyright 2025
Yahoo
2 hours ago
- Yahoo
Prediction: This Magnificent Artificial Intelligence (AI) Stock Will Be the Most Valuable Company in the World by 2030 (Hint: It's Not Nvidia or Microsoft)
Nvidia is currently the most valuable company in the world with a market capitalization of nearly $4 trillion. While Microsoft trails Nvidia by a small margin, both companies are facing rising competition in their core businesses -- making future growth less predictable. Amazon is still in the early phases of integrating artificial intelligence (AI) across its ecosystem, and recent valuation trends could suggest that investors are expecting robust growth on the horizon. 10 stocks we like better than Amazon › For about a year now, semiconductor powerhouse Nvidia and cloud computing giant Microsoft have been trading places for the most valuable company in the world. But as Nvidia inches closer to the coveted $4 trillion milestone, it might seem like the company is leaving its "Magnificent Seven" peers in the dust. Although Nvidia currently holds the title for the most valuable company, I think e-commerce and cloud infrastructure specialist Amazon (NASDAQ: AMZN) has a better shot at becoming the larger company in the long run. Let's explore the variety of ways that Amazon is already leveraging AI across its business and detail why the company's robust growth prospects could lead to a considerable expansion in valuation over the next five years. Amazon's ecosystem spans e-commerce, logistics, consumer electronics, cloud computing, advertising, streaming, and much more. While AI has the potential to add value to each of these services, I think investors should hone in on how the technology could ignite significant growth across the cloud and e-commerce segments in particular. Amazon derives the majority of its revenue from online sales, which generated a whopping $250 billion over the last year. Factors such as commoditized product offerings, expensive transportation infrastructure at global scale, and fluctuating shopping patterns from consumers make the e-commerce business a relatively low-margin business for Amazon, though. Management has expressed intentions to make this area of the business more profitable by leveraging AI-powered robotics. Robotics can be integrated in Amazon's warehouses to help automate mundane tasks alongside the human labor force. In addition, CEO Andy Jassy has even expressed that robots could assist in transportation and delivery of packages down the road. Per a recent analysis from Morgan Stanley, robotics could help reduce costs by 25% in an individual warehouse. Considering Amazon has global scale, these cost reductions could theoretically expand profitability in e-commerce operations by billions in the long run. Regarding its cloud business, Amazon has invested $8 billion into a start-up called Anthropic over the last couple of years. Anthropic's services have been swiftly integrated into Amazon Web Services (AWS), and its impact on the business' sales and profitability are already quite significant. For much of the last couple of years, Nvidia's graphics processing units (GPUs) have been considered the gold standard for generative AI development. And while many of the Magnificent Seven companies are Nvidia's largest customers today, these dynamics may shift in coming years. Although Nvidia and Microsoft are valued at premiums right now, I think both companies could struggle to fend off competition in the chip and cloud arenas. AMZN PE Ratio (Forward) data by YCharts Microsoft's partnership with OpenAI may not be as lucrative as it once was, given the ChatGPT maker has been exploring partnership opportunities with Alphabet and Oracle as of late. In addition, Amazon, Microsoft, and Alphabet are all investing significant capital in their own custom silicon development. Moreover, Advanced Micro Devices has built formidable data center and AI chip businesses that compete directly with Nvidia. Amazon appears to be witnessing a degree of expansion based on the forward price-to-earnings (P/E) trends pictured above. To me, this signals that investors may finally be understanding that Amazon is uniquely positioned to further monetize its various service offerings by augmenting its ecosystem with AI. Hence, the company's market cap could rise considerably relative to its peers in the following years as AI becomes the core pillar supporting Amazon's transformation. Although Amazon stock isn't a bargain now, I still see it as a compelling buy-and-hold opportunity for long-term investors. I do not think the upside that AI carries has been fully baked into the stock price, despite some noticeable expansion in recent months. Considering the long-term accretive impacts AI could generate for Amazon's core e-commerce and cloud businesses, I think the company is in the early phases of a new growth chapter featuring accelerating revenue and profits for years to come. For this reason, I think investors could continue valuing Amazon at a premium relative to its peers and see the company emerging as the most valuable business in the world over its AI peers by early the next decade. Before you buy stock in Amazon, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Amazon wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!* Now, it's worth noting Stock Advisor's total average return is 1,047% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of July 7, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Adam Spatacco has positions in Alphabet, Amazon, Microsoft, and Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Alphabet, Amazon, Microsoft, Nvidia, and Oracle. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Prediction: This Magnificent Artificial Intelligence (AI) Stock Will Be the Most Valuable Company in the World by 2030 (Hint: It's Not Nvidia or Microsoft) was originally published by The Motley Fool
Yahoo
5 hours ago
- Yahoo
Extended Amazon Prime Day AirPods deal: Canadians can score a rare sale price on Apple AirPods Pro 2 — but they're selling fast
Amazon Prime Day 2025 is over — but there are hundreds of extended deals still going strong, including a rare sale on Apple AirPods Pro 2 Wireless Earbuds. For a limited time, Prime members (sign up for a free trial here) can still save a whopping $82 on the wireless headphones. If you're familiar with Apple pricing, you'll know that deals as good as 25 per cent off are hard to come by. The AirPods have earned more than 26,000 reviews and a 4.6-star average rating, earning a coveted "Amazon's Choice" title. To see why they are, indeed, worth the hype and shop the extended Prime Day deal, scroll below. With six hours of listening time on a single charge and up to 30 hours when using the MagSafe Charging Case (included), the AirPods boast impressive battery life. It comes with four silicone tips that help you achieve a secure and comfortable fit, while also keeping sound in and external noise out. The AirPods resist dust, sweat and water, making them suitable for sweaty workouts or outdoor activities while also providing intelligent noise control. It also features an H2 chip, which provides deep, immersive sound with rich bass and overall improved definition. In terms of control, the earbuds operate via touch features and Siri Interactions. For instance, if you receive a phone call, either nod your head or shake your head, and Siri will respond accordingly. 🛍️ 26,000+ reviews ⭐ 4.6-star average rating 🏅Shoppers say they are "absolutely blown away" by the "game-changer" earbuds. Amazon reviewers share that the "sound performance is exceptional" and that it gives "rich, balanced audio." One person notes that the noise-cancelling technology is "fabulous" and that they can "barely hear [their husband snoring] beside them." They also note that the wireless charging case "is convenient" and that the battery "lasts long enough for a full day of use." $247 $329 at Amazon Others say that it's an impressive mix of "advanced technology and user-friendly design" and that the ergonomic fit gives "comfort during extended use." "A top-tier choice among wireless earbuds," writes one person, with another saying that the "seamless connection" between their iPhone, iPad and MacBook is "nothing short of magical." "I am absolutely blown away by the experience!" writes one shopper. "These earbuds are a game-changer in every sense." If you're looking for a more affordable model, the Apple AirPods 4 are also on sale for $199. Shoppers say that the Apple AirPods Pro 2 Wireless Earbuds deliver impressive sound quality, have great battery life and are comfortable to wear all day. They also appreciate that it seamlessly transitions between various Apple devices without requiring adjustments to Bluetooth settings. Right now, you can get the earbuds for $82 off — this deal could sell out quickly, so you might want to get your shopping done sooner rather than later.
